This message was sent to ##Email##
To advertise in this publication please click here
Advertisement
|
|
Advertisement
|
Check out Next Week's SLAS Transformed 2020 Lineup
Join experts from the Massachusetts Institute of Technology (MIT), Mammoth Biosciences, the National Center for Advancing Translational Sciences, Recursion Pharmaceuticals, Bd Biosciences, the Northrup Consulting Group, ArsenalBio, Ginkgo Bioworks, the Weizmann Institute of Science, Intellia Therapeutics and Harvard Medical School at next week’s SLAS Transformed 2020 virtual event. Invite your colleagues from around the world — morning, afternoon, and early evening sessions will be available both Tuesday and Wednesday, Jun 23-24.
REGISTER NOW
|
Last Chance to Reserve Your Spot at SLAS Transformed 2020
SLAS
The final touches are being but together for the first-ever SLAS virtual conference, SLAS Transformed 2020. Reserve your spot and join us for thirty-minute scientific sessions with live Q&A that will alternate with vendor tutorials and dedicated exhibition engagement time. SLAS Transformed 2020 will be presented within an easy-to-navigate and interactive platform allowing for simultaneous small group video chat and one-on-one on-demand networking all day. Plus, attendees can participate and compete for badges and prizes each day. The can’t miss sessions include:
- In vivo Delivery of Nucleic Acids, Genome Editing Tools and Cells
- Detection of SARS-CoV-2 with the CRISPR-based DETECTR Platform
- Synthetic Biology — Biology by Design
- Drug Repurposing for COVID-19 and the NCATS Open Data Portal
- Applying AI to Accelerate Assay Development to Pandemic Speed
- Testing Multiple Approaches to Decrease Sequencing Costs and Efficiently Distribute Sequencing Reads for Simultaneous Protein and mRNA Quantification at the Single Cell Level
- The Journey from Chip to COVID
- Developing a New Class of Cell Therapies at the Intersection of Synthetic Biology and Genome Engineering
- Vignettes of the COVID-19 Crisis Driving Sequencing Innovation
- Identifying Regional Outbreak and Spread of COVID-19 from Population-wide Surveys
- A Fully Automated Platform to Detect On-Target CRISPR/Cas9 Genome Editing
- Ultrasensitive Protein Assays for the COVID-19 Pandemic
REGISTER NOW
VIEW SCHEDULE-AT-A-GLANCE
|
|
Advertisement
SLAS Is Looking Towards 2021
SLAS
It’s the time of year when the SLAS2021 Scientific Program Committee is busy building jam-packed session tracks for the 10th SLAS International Conference and Exhibition. Do you have research to share? Submit an abstract for your chance to present at SLAS2021. Applications for the SLAS Student Poster Award, SLAS Tony B. Academic Travel Award and Innovation Award are also available through the abstract submission system. Submissions will be considered for 10 scientific tracks:
- Advances in Bioanalytics and Biomarkers
- Assay Development and Screening
- Automation Technologies
- Cellular Technologies
- Data Analysis and Informatics
- Drug Target Strategies
- Micro- and Nanotechnologies
- New Modalities
- 'Omics
- Precision Medicine for Drug Discovery
Presenting your research at SLAS2021 is a valuable opportunity to get in front of researchers, scientists, entrepreneurs and other technology professionals who are in search of the latest data and potential collaboration opportunities.
VIEW SLAS2021 ABSTRACT AND AWARD SUBMISSION DETAILS
|
|
|
|
 |
|
The coronavirus (COVID-19) is a rapidly evolving threat, and the synthetic DNA that can help discover a vaccine and treatment is needed now — not in eight to ten weeks. SGI-DNA is supporting front-line researchers in combating the spread of COVID-19 by offering $50,000 in co-funding for the BioXp™ 3200 system.
|
|
Innovation AveNEW is Looking for the Next Big Life Sciences and Tech Companies
SLAS
Start-ups and emerging technology companies: gain needed exposure for your products and/or services at SLAS2021 (and beyond) by applying for a spot on Innovation AveNEW, a specially designated area within the SLAS2021 Exhibition. Companies chosen for Innovation AveNEW forgo exhibition fees and travel costs and receive placement within a highly collaborative section of the exhibit floor that directly connects them with purchasing influencers and decision-makers from around the world. Innovation AveNEW companies are also invited to compete for the SLAS Ignite Award which recognizes the best start-up or emerging company.
LEARN MORE
|
|
Find Answers Faster
SLAS
In the latest New Matter: Behind the Minds of SLAS Scientists podcast, Ed Chow, Ph.D. (National University of Singapore) and Dean Ho, Ph.D. (Singapore Institute for Neurotechnology) discuss their new Identif.AI platform, which can help uncover non-obvious drug combinations to treat cancer, infectious diseases and suggest new therapies against SARS-CoV-2 infection. Other recently uploaded New Matter podcasts include:
|
|
Iscaffpharma
 Sortina Pharma use Iscaffpharma’s patient derived scaffolds to create drug fingerprints and select drugs for aggressive cancer. Read Case
 |
|
Promoted by
Thermo Scientific
The Thermo Scientific™ Orbitor™ RS2 microplate mover is a collaborative bench-top mover that provides unbeatable reliability and improved process efficiency. It’s innovative bi-directional telescoping arm coupled with it’s expansive 360° workspace provide exceptional reach and precision, making the Orbitor RS2 your trusted laboratory productivity partner.
|
|
Calendar of Important Dates
SLAS
SLAS Events Outlook
SLAS is committed to providing a safe meeting space, high-quality education and meaningful networking opportunities for all attendees, whether in person or on a virtual platform, as circumstances warrant. We look forward to convening in person but will do so only if we can provide a safe and appropriate meeting venue as well as suitable accommodations for travelers. The SLAS team is monitoring all aspects of event logistics and solidifying plans to enable alternative forms of knowledge sharing.
Save the Date
SLAS Transformed — Last Chance to Register
June 23 – 24, 2020
Virtual Event
SLAS 2020 AI Meets Sample Management Symposium – Registration Opens Early July
Boston, MA, USA
November 4 – 5, 2020
SLAS 2020 Building Biology in 3D Symposium – Registration Opens Early July
Scripps Research, Jupiter, FL, USA
November 17 – 18, 2020
SLAS 2021 International Conference and Exhibition — Now Accepting Podium and Poster Abstracts
San Diego, CA, USA
January 23 – 27, 2021
COMPLETE LIST OF SLAS CONFERENCES AND SYMPOSIA
|
|
|
|
 |
|
Evotec’s broad range of sample management capabilities in drug discovery and
 bioanalysis, many years of experience and continued investments in innovation and technology enable us to meet all customers’ needs and deadlines. Find out how the expertise of a global leader in sample management can help your projects.
|
|
Chemical Discovery in the Era of Metabolomics
Journal of the American Chemical Society
Untargeted metabolomics aims to quantify the complete set of metabolites within a biological system, most commonly by liquid chromatography/mass spectrometry. Since nearly the inception of the field, compound identification has been widely recognized as the rate-limiting step of the experimental workflow. In spite of exponential increases in the size of metabolomic databases, which now contain experimental MS/MS spectra for over a half a million reference compounds, chemical structures still cannot be confidently assigned to many signals in a typical LC/MS dataset.
|
|
New COVID-19 Antibody Test Targets Unique Region of Spike Protein
Genetic Engineering & Biotechnology News
A reliable antibody test for COVID-19 is critical to identify any and all individuals who have been infected with SARS-CoV-2, regardless of clinical symptoms. This serological test is urgently needed to conduct surveillance, gain a better understanding of infection rates — especially the number of infections in people with mild or no symptoms who can still be carriers — and implement strategies to contain spread.
|
|
Hydroxychloroquine Trials in Turmoil
Chemical & Engineering News
Clinical studies continue to suggest that the antimalarial drugs chloroquine and hydroxychloroquine do not help treat or prevent COVID-19. One high-profile study published in the Lancet even concluded that the drugs may increase the risk of death. Those results prompted several groups, including the World Health Organization and the pharmaceutical company Sanofi, to suspend or terminate trials of the drugs.
|
|
Could Statins Reduce the Severity of COVID-19?
The Scientist
On March 21, epidemiologist Haleema Shakur-Still got a WhatsApp message from Temitayo Shokunbi, a colleague at the University of Ibadan in Nigeria. He asked about starting a trial for treating COVID-19 patients with the drug hydroxychloroquine. At the time, several trials were already in the works to investigate the effectiveness of the antimalarial to counter SARS-CoV-2, the virus that causes COVID-19, so Shakur-Still didn’t think starting another one on the antimalarial would add much new information.
|
|
Cutting-Edge Computing Paves Way to Future of NMR Spectroscopy
Phys.org
Nuclear magnetic resonance spectroscopy helps chemists and other scientists identify and explore atomic structures. However, NMR is limited by the availability of catalogs of reference data to compare and identify structures.
New collaborative research leveraged quantum chemistry approaches to develop additional data infrastructure for an isotope of silicon, 29Si.
|
|
Lab Makes 4-D Printing More Practical
Science Daily
Soft robots and biomedical implants that reconfigure themselves upon demand are closer to reality with a new way to print shapeshifting materials.
Rafael Verduzco and graduate student Morgan Barnes of Rice's Brown School of Engineering developed a method to print objects that can be manipulated to take on alternate forms when exposed to changes in temperature, electric current or stress.
|
|
Computer Algorithms Find Tumors' Molecular Weak Spots
Science Magazine
In 2016, doctors invited Eileen Kapotes to join a clinical trial for a drug that had never been used for her disease. Kapotes, a first grade teacher in her 50s, was fighting an aggressive breast cancer that had spread through her body. She had endured grueling treatments over the previous 4 years, including whole-brain radiation therapy. She had also been taking the breast cancer medication Herceptin, but her tumors were still growing.
|
|
How Sugar-Tagging Helps Drugs Target Prostate Cancer Cells
Lab Manager
Scientists of Far Eastern Federal University, together with German and Russian colleagues, have developed a lead compound to fight chemotherapy-resistant prostate cancer. The original design comes from scientists combining biologically active molecules from the chemically modified pigment of sea urchins with glucose molecules to deliver the active drug substance to the tumor cells. A related article recently was published in Marine Drugs.
|
|
Job Seekers: Post your résumé and sign up for new job alerts by keyword.
Employers: Search résumés, post an open position, internship or post-doc opportunity. SLAS Premier and Corporate Members get a discount on all new job postings.
Automation Engineer
PACT Pharma
US – CA – South San Francisco
Postdoctoral Fellow/Microbiology, Immunology and Biochemistry
University of Tennessee Health Science Center
US – TN – Memphis
Research Scientist
University of Pittsburgh
US – PA – Pittsburgh
Search Jobs at SLAS Career Connections
| . |
| THANK YOU |
|
2020 SLAS CORPORATE MEMBERS |
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
